Sermorelin, which is a peptide analog of a growth hormone releasing GHRH, which is thought to increase human growth hormone levels to improve muscle mass, decrease body fat, and help energy levels
Pooled safety data across 12 placebo-controlled clinical studies of glycemic control in adults with T2D 1 Adverse reactions reported in 2% of adults taking FARXIGA 10 mg (n=1193) vs placebo (n=1393) included female genital mycotic infections (6.9% vs 1.5%), nasopharyngitis (6.3% vs 6.2%), UTIs (4.3% vs 3.7%), back pain (4.2% vs 3.2%), increased urination (3.8% vs 1.7%), male genital mycotic infections (2.7% vs 0.3%), nausea (2.5% vs 2.4%), dyslipidemia (2.5% vs 1.5%), influenza (2.3% vs 2.3%), and discomfort with urination (2.1% vs 0.7%)
The scientific beauty of both systems lies in the disproportionate differences between the mechanisms and their outcomes
Semaglutide's gastrointestinal effects vary by product and dose: nausea (20-44%), vomiting (9-24%), and diarrhea (9-30%) according to FDA prescribing information
Studies show accelerated healing of injuries and wounds, improved tendon and ligament repair, enhanced bone healing after fractures, better overall tissue regrowth, and reduced healing time from injuries
10.1186/s13048-014-0093-3 270 ZhangJ.ShengS.WangW.DaiJ.ZhongY.RenJ.et al (2022)
